This research report provides a comprehensive analysis of the RNA-based Therapeutics Drug market, focusing on the current trends, market dynamics, and future prospects. The report explores the global RNA-based Therapeutics Drug market, including major regions such as North America, Europe, Asia-Pacific, and emerging markets. It also examines key factors driving the growth of RNA-based Therapeutics Drug, challenges faced by the industry, and potential opportunities for market players.
The global RNA-based Therapeutics Drug market has witnessed rapid growth in recent years, driven by increasing environmental concerns, government incentives, and advancements in technology. The RNA-based Therapeutics Drug market presents opportunities for various stakeholders, including Neuromuscular Diseases, hATTR. Collaboration between the private sector and governments can accelerate the development of supportive policies, research and development efforts, and investment in RNA-based Therapeutics Drug market. Additionally, the growing consumer demand present avenues for market expansion.
The global RNA-based Therapeutics Drug market was valued at US$ 60320 million in 2022 and is projected to reach US$ 14820 million by 2029, at a CAGR of 3.9% during the forecast period.
The Nucleic Acid-Based Therapeutics Drug Market is driven by the promising potential of nucleic acid-based therapies in treating various genetic and acquired diseases, including genetic disorders, cancer, and infectious diseases. These innovative drugs utilize nucleic acids, such as DNA or RNA, to modify or regulate gene expression, correct genetic mutations, or target specific disease-associated genes. As the understanding of genomics and molecular biology advances, and personalized medicine gains traction, the demand for nucleic acid-based therapeutics continues to grow. Innovations in drug development, delivery systems, and gene editing technologies further contribute to market expansion. However, a significant challenge for this market is the need to address delivery and stability issues, ensure long-term safety and efficacy, and navigate regulatory complexities and patient acceptance. Overcoming technical and scientific hurdles, optimizing drug delivery methods, and addressing concerns about off-target effects are ongoing challenges. Additionally, the market faces competition from conventional therapies and the need for continuous research and development to unlock the full therapeutic potential of nucleic acid-based drugs. Striking a balance between providing safe, effective, and accessible nucleic acid-based therapeutics while addressing scientific and regulatory challenges is essential for the continued growth of the Nucleic Acid-Based Therapeutics Drug Market.
Key Features:
The research report on the RNA-based Therapeutics Drug market includes several key features to provide comprehensive insights and facilitate decision-making for stakeholders.
Executive Summary: The report provides overview of the key findings, market trends, and major insights of the RNA-based Therapeutics Drug market.
Market Overview: The report provides a comprehensive overview of the RNA-based Therapeutics Drug market, including its definition, historical development, and current market size. It covers market segmentation by Type e.g., Antisense Oligonucleotides ASO, siRNA, region, and application, highlighting the key drivers, challenges, and opportunities within each segment.
Market Dynamics: The report analyses the market dynamics driving the growth and development of the RNA-based Therapeutics Drug market. The report includes an assessment of government policies and regulations, technological advancements, consumer trends and preferences, infrastructure development, and industry collaborations. This analysis helps stakeholders understand the factors influencing the RNA-based Therapeutics Drug markets trajectory.
Competitive Landscape: The report provides an in-depth analysis of the competitive landscape within the RNA-based Therapeutics Drug market. It includes profiles of major market players, their market share, strategies, product portfolios, and recent developments.
Market Segmentation and Forecast: The report segment the RNA-based Therapeutics Drug market based on various parameters, such as by Type, region, and by Application. It provides market size and growth forecasts for each segment, supported by quantitative data and analysis. This helps stakeholders identify growth opportunities and make informed investment decisions.
Technological Trends: The report should highlight the key technological trends shaping the RNA-based Therapeutics Drug market, such as advancements in Type One technology and emerging substitutes. It analyses the impact of these trends on market growth, adoption rates, and consumer preferences.
Market Challenges and Opportunities: The report identify and analyses the major challenges faced by the RNA-based Therapeutics Drug market, such as technical bottleneck, cost limitations, and high entry barrier. It also highlights the opportunities for market growth, such as government incentives, emerging markets, and collaborations between stakeholders.
Regulatory and Policy Analysis: The report should assess the regulatory and policy landscape for RNA-based Therapeutics Drug, including government incentives, emission standards, and infrastructure development plans. It should analyse the impact of these policies on market growth and provide insights into future regulatory developments.
Recommendations and Conclusion: The report conclude with actionable recommendations for stakeholders, such as Application One Consumer, policymakers, investors, and infrastructure providers. These recommendations should be based on the research findings and address key challenges and opportunities within the RNA-based Therapeutics Drug market.
Supporting Data and Appendices: The report include supporting data, charts, and graphs to substantiate the analysis and findings. It also includes appendices with additional detailed information, such as data sources, survey questionnaires, and detailed market forecasts.
Market Segmentation
RNA-based Therapeutics Drug market is split by Type and by Application. For the period 2018-2029, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of value.
Market segment by Type
Antisense Oligonucleotides ASO
siRNA
mRNA
Market segment by Application
Neuromuscular Diseases
hATTR
COVID-19
Other
Global RNA-based Therapeutics Drug Market Segment Percentages, By Region and Country, 2022 %
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Major players covered
Sarepta Therapeutics
Ionis Pharmaceuticals
Alnylam
Biogen
Nippon Shinyaku
Sobi
Novartis
BioNTech
Pfizer
Moderna Therapeutics
Jazz Pharmaceuticals
CureVac
Regulus Therapeutics
ProQR
Secarna
MiNA Therapeutics
Sylentis
Arrowhead
Silence Therapeutics
Dicerna
Outline of Major Chapters:
Chapter 1: Introduces the definition of RNA-based Therapeutics Drug, market overview.
Chapter 2: Global RNA-based Therapeutics Drug market size in revenue.
Chapter 3: Detailed analysis of RNA-based Therapeutics Drug company competitive landscape, revenue and market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Sales of RNA-based Therapeutics Drug in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 8: The main points and conclusions of the report.
1 Introduction to Research & Analysis Reports
1.1 RNA-based Therapeutics Drug Market Definition
1.2 Market Segments
1.2.1 Market by Type
1.2.2 Market by Application
1.3 Global RNA-based Therapeutics Drug Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
1.5.1 Research Methodology
1.5.2 Research Process
1.5.3 Base Year
1.5.4 Report Assumptions & Caveats
2 Global RNA-based Therapeutics Drug Overall Market Size
2.1 Global RNA-based Therapeutics Drug Market Size: 2022 VS 2029
2.2 Global RNA-based Therapeutics Drug Market Size, Prospects & Forecasts: 2018-2029
2.3 Key Market Trends, Opportunity, Drivers and Restraints
2.3.1 Market Opportunities & Trends
2.3.2 Market Drivers
2.3.3 Market Restraints
3 Company Landscape
3.1 Top RNA-based Therapeutics Drug Players in Global Market
3.2 Top Global RNA-based Therapeutics Drug Companies Ranked by Revenue
3.3 Global RNA-based Therapeutics Drug Revenue by Companies
3.4 Top 3 and Top 5 RNA-based Therapeutics Drug Companies in Global Market, by Revenue in 2022
3.5 Global Companies RNA-based Therapeutics Drug Product Type
3.6 Tier 1, Tier 2 and Tier 3 RNA-based Therapeutics Drug Players in Global Market
3.6.1 List of Global Tier 1 RNA-based Therapeutics Drug Companies
3.6.2 List of Global Tier 2 and Tier 3 RNA-based Therapeutics Drug Companies
4 Market Sights by Product
4.1 Overview
4.1.1 By Type - Global RNA-based Therapeutics Drug Market Size Markets, 2022 & 2029
4.1.2 Antisense Oligonucleotides ASO
4.1.3 siRNA
4.1.4 mRNA
4.2 By Type - Global RNA-based Therapeutics Drug Revenue & Forecasts
4.2.1 By Type - Global RNA-based Therapeutics Drug Revenue, 2018-2023
4.2.2 By Type - Global RNA-based Therapeutics Drug Revenue, 2024-2029
4.2.3 By Type - Global RNA-based Therapeutics Drug Revenue Market Share, 2018-2029
5 Sights by Application
5.1 Overview
5.1.1 By Application - Global RNA-based Therapeutics Drug Market Size, 2022 & 2029
5.1.2 Neuromuscular Diseases
5.1.3 hATTR
5.1.4 COVID-19
5.1.5 Other
5.2 By Application - Global RNA-based Therapeutics Drug Revenue & Forecasts
5.2.1 By Application - Global RNA-based Therapeutics Drug Revenue, 2018-2023
5.2.2 By Application - Global RNA-based Therapeutics Drug Revenue, 2024-2029
5.2.3 By Application - Global RNA-based Therapeutics Drug Revenue Market Share, 2018-2029
6 Sights by Region
6.1 By Region - Global RNA-based Therapeutics Drug Market Size, 2022 & 2029
6.2 By Region - Global RNA-based Therapeutics Drug Revenue & Forecasts
6.2.1 By Region - Global RNA-based Therapeutics Drug Revenue, 2018-2023
6.2.2 By Region - Global RNA-based Therapeutics Drug Revenue, 2024-2029
6.2.3 By Region - Global RNA-based Therapeutics Drug Revenue Market Share, 2018-2029
6.3 North America
6.3.1 By Country - North America RNA-based Therapeutics Drug Revenue, 2018-2029
6.3.2 US RNA-based Therapeutics Drug Market Size, 2018-2029
6.3.3 Canada RNA-based Therapeutics Drug Market Size, 2018-2029
6.3.4 Mexico RNA-based Therapeutics Drug Market Size, 2018-2029
6.4 Europe
6.4.1 By Country - Europe RNA-based Therapeutics Drug Revenue, 2018-2029
6.4.2 Germany RNA-based Therapeutics Drug Market Size, 2018-2029
6.4.3 France RNA-based Therapeutics Drug Market Size, 2018-2029
6.4.4 U.K. RNA-based Therapeutics Drug Market Size, 2018-2029
6.4.5 Italy RNA-based Therapeutics Drug Market Size, 2018-2029
6.4.6 Russia RNA-based Therapeutics Drug Market Size, 2018-2029
6.4.7 Nordic Countries RNA-based Therapeutics Drug Market Size, 2018-2029
6.4.8 Benelux RNA-based Therapeutics Drug Market Size, 2018-2029
6.5 Asia
6.5.1 By Region - Asia RNA-based Therapeutics Drug Revenue, 2018-2029
6.5.2 China RNA-based Therapeutics Drug Market Size, 2018-2029
6.5.3 Japan RNA-based Therapeutics Drug Market Size, 2018-2029
6.5.4 South Korea RNA-based Therapeutics Drug Market Size, 2018-2029
6.5.5 Southeast Asia RNA-based Therapeutics Drug Market Size, 2018-2029
6.5.6 India RNA-based Therapeutics Drug Market Size, 2018-2029
6.6 South America
6.6.1 By Country - South America RNA-based Therapeutics Drug Revenue, 2018-2029
6.6.2 Brazil RNA-based Therapeutics Drug Market Size, 2018-2029
6.6.3 Argentina RNA-based Therapeutics Drug Market Size, 2018-2029
6.7 Middle East & Africa
6.7.1 By Country - Middle East & Africa RNA-based Therapeutics Drug Revenue, 2018-2029
6.7.2 Turkey RNA-based Therapeutics Drug Market Size, 2018-2029
6.7.3 Israel RNA-based Therapeutics Drug Market Size, 2018-2029
6.7.4 Saudi Arabia RNA-based Therapeutics Drug Market Size, 2018-2029
6.7.5 UAE RNA-based Therapeutics Drug Market Size, 2018-2029
7 RNA-based Therapeutics Drug Companies Profiles
7.1 Sarepta Therapeutics
7.1.1 Sarepta Therapeutics Company Summary
7.1.2 Sarepta Therapeutics Business Overview
7.1.3 Sarepta Therapeutics RNA-based Therapeutics Drug Major Product Offerings
7.1.4 Sarepta Therapeutics RNA-based Therapeutics Drug Revenue in Global Market 2018-2023
7.1.5 Sarepta Therapeutics Key News & Latest Developments
7.2 Ionis Pharmaceuticals
7.2.1 Ionis Pharmaceuticals Company Summary
7.2.2 Ionis Pharmaceuticals Business Overview
7.2.3 Ionis Pharmaceuticals RNA-based Therapeutics Drug Major Product Offerings
7.2.4 Ionis Pharmaceuticals RNA-based Therapeutics Drug Revenue in Global Market 2018-2023
7.2.5 Ionis Pharmaceuticals Key News & Latest Developments
7.3 Alnylam
7.3.1 Alnylam Company Summary
7.3.2 Alnylam Business Overview
7.3.3 Alnylam RNA-based Therapeutics Drug Major Product Offerings
7.3.4 Alnylam RNA-based Therapeutics Drug Revenue in Global Market 2018-2023
7.3.5 Alnylam Key News & Latest Developments
7.4 Biogen
7.4.1 Biogen Company Summary
7.4.2 Biogen Business Overview
7.4.3 Biogen RNA-based Therapeutics Drug Major Product Offerings
7.4.4 Biogen RNA-based Therapeutics Drug Revenue in Global Market 2018-2023
7.4.5 Biogen Key News & Latest Developments
7.5 Nippon Shinyaku
7.5.1 Nippon Shinyaku Company Summary
7.5.2 Nippon Shinyaku Business Overview
7.5.3 Nippon Shinyaku RNA-based Therapeutics Drug Major Product Offerings
7.5.4 Nippon Shinyaku RNA-based Therapeutics Drug Revenue in Global Market 2018-2023
7.5.5 Nippon Shinyaku Key News & Latest Developments
7.6 Sobi
7.6.1 Sobi Company Summary
7.6.2 Sobi Business Overview
7.6.3 Sobi RNA-based Therapeutics Drug Major Product Offerings
7.6.4 Sobi RNA-based Therapeutics Drug Revenue in Global Market 2018-2023
7.6.5 Sobi Key News & Latest Developments
7.7 Novartis
7.7.1 Novartis Company Summary
7.7.2 Novartis Business Overview
7.7.3 Novartis RNA-based Therapeutics Drug Major Product Offerings
7.7.4 Novartis RNA-based Therapeutics Drug Revenue in Global Market 2018-2023
7.7.5 Novartis Key News & Latest Developments
7.8 BioNTech
7.8.1 BioNTech Company Summary
7.8.2 BioNTech Business Overview
7.8.3 BioNTech RNA-based Therapeutics Drug Major Product Offerings
7.8.4 BioNTech RNA-based Therapeutics Drug Revenue in Global Market 2018-2023
7.8.5 BioNTech Key News & Latest Developments
7.9 Pfizer
7.9.1 Pfizer Company Summary
7.9.2 Pfizer Business Overview
7.9.3 Pfizer RNA-based Therapeutics Drug Major Product Offerings
7.9.4 Pfizer RNA-based Therapeutics Drug Revenue in Global Market 2018-2023
7.9.5 Pfizer Key News & Latest Developments
7.10 Moderna Therapeutics
7.10.1 Moderna Therapeutics Company Summary
7.10.2 Moderna Therapeutics Business Overview
7.10.3 Moderna Therapeutics RNA-based Therapeutics Drug Major Product Offerings
7.10.4 Moderna Therapeutics RNA-based Therapeutics Drug Revenue in Global Market 2018-2023
7.10.5 Moderna Therapeutics Key News & Latest Developments
7.11 Jazz Pharmaceuticals
7.11.1 Jazz Pharmaceuticals Company Summary
7.11.2 Jazz Pharmaceuticals Business Overview
7.11.3 Jazz Pharmaceuticals RNA-based Therapeutics Drug Major Product Offerings
7.11.4 Jazz Pharmaceuticals RNA-based Therapeutics Drug Revenue in Global Market 2018-2023
7.11.5 Jazz Pharmaceuticals Key News & Latest Developments
7.12 CureVac
7.12.1 CureVac Company Summary
7.12.2 CureVac Business Overview
7.12.3 CureVac RNA-based Therapeutics Drug Major Product Offerings
7.12.4 CureVac RNA-based Therapeutics Drug Revenue in Global Market 2018-2023
7.12.5 CureVac Key News & Latest Developments
7.13 Regulus Therapeutics
7.13.1 Regulus Therapeutics Company Summary
7.13.2 Regulus Therapeutics Business Overview
7.13.3 Regulus Therapeutics RNA-based Therapeutics Drug Major Product Offerings
7.13.4 Regulus Therapeutics RNA-based Therapeutics Drug Revenue in Global Market 2018-2023
7.13.5 Regulus Therapeutics Key News & Latest Developments
7.14 ProQR
7.14.1 ProQR Company Summary
7.14.2 ProQR Business Overview
7.14.3 ProQR RNA-based Therapeutics Drug Major Product Offerings
7.14.4 ProQR RNA-based Therapeutics Drug Revenue in Global Market 2018-2023
7.14.5 ProQR Key News & Latest Developments
7.15 Secarna
7.15.1 Secarna Company Summary
7.15.2 Secarna Business Overview
7.15.3 Secarna RNA-based Therapeutics Drug Major Product Offerings
7.15.4 Secarna RNA-based Therapeutics Drug Revenue in Global Market 2018-2023
7.15.5 Secarna Key News & Latest Developments
7.16 MiNA Therapeutics
7.16.1 MiNA Therapeutics Company Summary
7.16.2 MiNA Therapeutics Business Overview
7.16.3 MiNA Therapeutics RNA-based Therapeutics Drug Major Product Offerings
7.16.4 MiNA Therapeutics RNA-based Therapeutics Drug Revenue in Global Market 2018-2023
7.16.5 MiNA Therapeutics Key News & Latest Developments
7.17 Sylentis
7.17.1 Sylentis Company Summary
7.17.2 Sylentis Business Overview
7.17.3 Sylentis RNA-based Therapeutics Drug Major Product Offerings
7.17.4 Sylentis RNA-based Therapeutics Drug Revenue in Global Market 2018-2023
7.17.5 Sylentis Key News & Latest Developments
7.18 Arrowhead
7.18.1 Arrowhead Company Summary
7.18.2 Arrowhead Business Overview
7.18.3 Arrowhead RNA-based Therapeutics Drug Major Product Offerings
7.18.4 Arrowhead RNA-based Therapeutics Drug Revenue in Global Market 2018-2023
7.18.5 Arrowhead Key News & Latest Developments
7.19 Silence Therapeutics
7.19.1 Silence Therapeutics Company Summary
7.19.2 Silence Therapeutics Business Overview
7.19.3 Silence Therapeutics RNA-based Therapeutics Drug Major Product Offerings
7.19.4 Silence Therapeutics RNA-based Therapeutics Drug Revenue in Global Market 2018-2023
7.19.5 Silence Therapeutics Key News & Latest Developments
7.20 Dicerna
7.20.1 Dicerna Company Summary
7.20.2 Dicerna Business Overview
7.20.3 Dicerna RNA-based Therapeutics Drug Major Product Offerings
7.20.4 Dicerna RNA-based Therapeutics Drug Revenue in Global Market 2018-2023
7.20.5 Dicerna Key News & Latest Developments
8 Conclusion
9 Appendix
9.1 Note
9.2 Examples of Clients
9.3 Disclaimer
List of Tables
Table 1. RNA-based Therapeutics Drug Market Opportunities & Trends in Global Market
Table 2. RNA-based Therapeutics Drug Market Drivers in Global Market
Table 3. RNA-based Therapeutics Drug Market Restraints in Global Market
Table 4. Key Players of RNA-based Therapeutics Drug in Global Market
Table 5. Top RNA-based Therapeutics Drug Players in Global Market, Ranking by Revenue 2022
Table 6. Global RNA-based Therapeutics Drug Revenue by Companies, US$, Mn, 2018-2023
Table 7. Global RNA-based Therapeutics Drug Revenue Share by Companies, 2018-2023
Table 8. Global Companies RNA-based Therapeutics Drug Product Type
Table 9. List of Global Tier 1 RNA-based Therapeutics Drug Companies, Revenue US$, Mn in 2022 and Market Share
Table 10. List of Global Tier 2 and Tier 3 RNA-based Therapeutics Drug Companies, Revenue US$, Mn in 2022 and Market Share
Table 11. By Type – Global RNA-based Therapeutics Drug Revenue, US$, Mn, 2022 & 2029
Table 12. By Type - RNA-based Therapeutics Drug Revenue in Global US$, Mn, 2018-2023
Table 13. By Type - RNA-based Therapeutics Drug Revenue in Global US$, Mn, 2024-2029
Table 14. By Application – Global RNA-based Therapeutics Drug Revenue, US$, Mn, 2022 & 2029
Table 15. By Application - RNA-based Therapeutics Drug Revenue in Global US$, Mn, 2018-2023
Table 16. By Application - RNA-based Therapeutics Drug Revenue in Global US$, Mn, 2024-2029
Table 17. By Region – Global RNA-based Therapeutics Drug Revenue, US$, Mn, 2022 & 2029
Table 18. By Region - Global RNA-based Therapeutics Drug Revenue US$, Mn, 2018-2023
Table 19. By Region - Global RNA-based Therapeutics Drug Revenue US$, Mn, 2024-2029
Table 20. By Country - North America RNA-based Therapeutics Drug Revenue, US$, Mn, 2018-2023
Table 21. By Country - North America RNA-based Therapeutics Drug Revenue, US$, Mn, 2024-2029
Table 22. By Country - Europe RNA-based Therapeutics Drug Revenue, US$, Mn, 2018-2023
Table 23. By Country - Europe RNA-based Therapeutics Drug Revenue, US$, Mn, 2024-2029
Table 24. By Region - Asia RNA-based Therapeutics Drug Revenue, US$, Mn, 2018-2023
Table 25. By Region - Asia RNA-based Therapeutics Drug Revenue, US$, Mn, 2024-2029
Table 26. By Country - South America RNA-based Therapeutics Drug Revenue, US$, Mn, 2018-2023
Table 27. By Country - South America RNA-based Therapeutics Drug Revenue, US$, Mn, 2024-2029
Table 28. By Country - Middle East & Africa RNA-based Therapeutics Drug Revenue, US$, Mn, 2018-2023
Table 29. By Country - Middle East & Africa RNA-based Therapeutics Drug Revenue, US$, Mn, 2024-2029
Table 30. Sarepta Therapeutics Company Summary
Table 31. Sarepta Therapeutics RNA-based Therapeutics Drug Product Offerings
Table 32. Sarepta Therapeutics RNA-based Therapeutics Drug Revenue US$, Mn & 2018-2023
Table 33. Sarepta Therapeutics Key News & Latest Developments
Table 34. Ionis Pharmaceuticals Company Summary
Table 35. Ionis Pharmaceuticals RNA-based Therapeutics Drug Product Offerings
Table 36. Ionis Pharmaceuticals RNA-based Therapeutics Drug Revenue US$, Mn & 2018-2023
Table 37. Ionis Pharmaceuticals Key News & Latest Developments
Table 38. Alnylam Company Summary
Table 39. Alnylam RNA-based Therapeutics Drug Product Offerings
Table 40. Alnylam RNA-based Therapeutics Drug Revenue US$, Mn & 2018-2023
Table 41. Alnylam Key News & Latest Developments
Table 42. Biogen Company Summary
Table 43. Biogen RNA-based Therapeutics Drug Product Offerings
Table 44. Biogen RNA-based Therapeutics Drug Revenue US$, Mn & 2018-2023
Table 45. Biogen Key News & Latest Developments
Table 46. Nippon Shinyaku Company Summary
Table 47. Nippon Shinyaku RNA-based Therapeutics Drug Product Offerings
Table 48. Nippon Shinyaku RNA-based Therapeutics Drug Revenue US$, Mn & 2018-2023
Table 49. Nippon Shinyaku Key News & Latest Developments
Table 50. Sobi Company Summary
Table 51. Sobi RNA-based Therapeutics Drug Product Offerings
Table 52. Sobi RNA-based Therapeutics Drug Revenue US$, Mn & 2018-2023
Table 53. Sobi Key News & Latest Developments
Table 54. Novartis Company Summary
Table 55. Novartis RNA-based Therapeutics Drug Product Offerings
Table 56. Novartis RNA-based Therapeutics Drug Revenue US$, Mn & 2018-2023
Table 57. Novartis Key News & Latest Developments
Table 58. BioNTech Company Summary
Table 59. BioNTech RNA-based Therapeutics Drug Product Offerings
Table 60. BioNTech RNA-based Therapeutics Drug Revenue US$, Mn & 2018-2023
Table 61. BioNTech Key News & Latest Developments
Table 62. Pfizer Company Summary
Table 63. Pfizer RNA-based Therapeutics Drug Product Offerings
Table 64. Pfizer RNA-based Therapeutics Drug Revenue US$, Mn & 2018-2023
Table 65. Pfizer Key News & Latest Developments
Table 66. Moderna Therapeutics Company Summary
Table 67. Moderna Therapeutics RNA-based Therapeutics Drug Product Offerings
Table 68. Moderna Therapeutics RNA-based Therapeutics Drug Revenue US$, Mn & 2018-2023
Table 69. Moderna Therapeutics Key News & Latest Developments
Table 70. Jazz Pharmaceuticals Company Summary
Table 71. Jazz Pharmaceuticals RNA-based Therapeutics Drug Product Offerings
Table 72. Jazz Pharmaceuticals RNA-based Therapeutics Drug Revenue US$, Mn & 2018-2023
Table 73. Jazz Pharmaceuticals Key News & Latest Developments
Table 74. CureVac Company Summary
Table 75. CureVac RNA-based Therapeutics Drug Product Offerings
Table 76. CureVac RNA-based Therapeutics Drug Revenue US$, Mn & 2018-2023
Table 77. CureVac Key News & Latest Developments
Table 78. Regulus Therapeutics Company Summary
Table 79. Regulus Therapeutics RNA-based Therapeutics Drug Product Offerings
Table 80. Regulus Therapeutics RNA-based Therapeutics Drug Revenue US$, Mn & 2018-2023
Table 81. Regulus Therapeutics Key News & Latest Developments
Table 82. ProQR Company Summary
Table 83. ProQR RNA-based Therapeutics Drug Product Offerings
Table 84. ProQR RNA-based Therapeutics Drug Revenue US$, Mn & 2018-2023
Table 85. ProQR Key News & Latest Developments
Table 86. Secarna Company Summary
Table 87. Secarna RNA-based Therapeutics Drug Product Offerings
Table 88. Secarna RNA-based Therapeutics Drug Revenue US$, Mn & 2018-2023
Table 89. Secarna Key News & Latest Developments
Table 90. MiNA Therapeutics Company Summary
Table 91. MiNA Therapeutics RNA-based Therapeutics Drug Product Offerings
Table 92. MiNA Therapeutics RNA-based Therapeutics Drug Revenue US$, Mn & 2018-2023
Table 93. MiNA Therapeutics Key News & Latest Developments
Table 94. Sylentis Company Summary
Table 95. Sylentis RNA-based Therapeutics Drug Product Offerings
Table 96. Sylentis RNA-based Therapeutics Drug Revenue US$, Mn & 2018-2023
Table 97. Sylentis Key News & Latest Developments
Table 98. Arrowhead Company Summary
Table 99. Arrowhead RNA-based Therapeutics Drug Product Offerings
Table 100. Arrowhead RNA-based Therapeutics Drug Revenue US$, Mn & 2018-2023
Table 101. Arrowhead Key News & Latest Developments
Table 102. Silence Therapeutics Company Summary
Table 103. Silence Therapeutics RNA-based Therapeutics Drug Product Offerings
Table 104. Silence Therapeutics RNA-based Therapeutics Drug Revenue US$, Mn & 2018-2023
Table 105. Silence Therapeutics Key News & Latest Developments
Table 106. Dicerna Company Summary
Table 107. Dicerna RNA-based Therapeutics Drug Product Offerings
Table 108. Dicerna RNA-based Therapeutics Drug Revenue US$, Mn & 2018-2023
Table 109. Dicerna Key News & Latest Developments
List of Figures
Figure 1. RNA-based Therapeutics Drug Segment by Type in 2022
Figure 2. RNA-based Therapeutics Drug Segment by Application in 2022
Figure 3. Global RNA-based Therapeutics Drug Market Overview: 2022
Figure 4. Key Caveats
Figure 5. Global RNA-based Therapeutics Drug Market Size: 2022 VS 2029 US$, Mn
Figure 6. Global RNA-based Therapeutics Drug Revenue, 2018-2029 US$, Mn
Figure 7. The Top 3 and 5 Players Market Share by RNA-based Therapeutics Drug Revenue in 2022
Figure 8. By Type - Global RNA-based Therapeutics Drug Revenue Market Share, 2018-2029
Figure 9. By Application - Global RNA-based Therapeutics Drug Revenue Market Share, 2018-2029
Figure 10. By Type - Global RNA-based Therapeutics Drug Revenue, US$, Mn, 2022 & 2029
Figure 11. By Type - Global RNA-based Therapeutics Drug Revenue Market Share, 2018-2029
Figure 12. By Application - Global RNA-based Therapeutics Drug Revenue, US$, Mn, 2022 & 2029
Figure 13. By Application - Global RNA-based Therapeutics Drug Revenue Market Share, 2018-2029
Figure 14. By Region - Global RNA-based Therapeutics Drug Revenue Market Share, 2018-2029
Figure 15. By Country - North America RNA-based Therapeutics Drug Revenue Market Share, 2018-2029
Figure 16. US RNA-based Therapeutics Drug Revenue, US$, Mn, 2018-2029
Figure 17. Canada RNA-based Therapeutics Drug Revenue, US$, Mn, 2018-2029
Figure 18. Mexico RNA-based Therapeutics Drug Revenue, US$, Mn, 2018-2029
Figure 19. By Country - Europe RNA-based Therapeutics Drug Revenue Market Share, 2018-2029
Figure 20. Germany RNA-based Therapeutics Drug Revenue, US$, Mn, 2018-2029
Figure 21. France RNA-based Therapeutics Drug Revenue, US$, Mn, 2018-2029
Figure 22. U.K. RNA-based Therapeutics Drug Revenue, US$, Mn, 2018-2029
Figure 23. Italy RNA-based Therapeutics Drug Revenue, US$, Mn, 2018-2029
Figure 24. Russia RNA-based Therapeutics Drug Revenue, US$, Mn, 2018-2029
Figure 25. Nordic Countries RNA-based Therapeutics Drug Revenue, US$, Mn, 2018-2029
Figure 26. Benelux RNA-based Therapeutics Drug Revenue, US$, Mn, 2018-2029
Figure 27. By Region - Asia RNA-based Therapeutics Drug Revenue Market Share, 2018-2029
Figure 28. China RNA-based Therapeutics Drug Revenue, US$, Mn, 2018-2029
Figure 29. Japan RNA-based Therapeutics Drug Revenue, US$, Mn, 2018-2029
Figure 30. South Korea RNA-based Therapeutics Drug Revenue, US$, Mn, 2018-2029
Figure 31. Southeast Asia RNA-based Therapeutics Drug Revenue, US$, Mn, 2018-2029
Figure 32. India RNA-based Therapeutics Drug Revenue, US$, Mn, 2018-2029
Figure 33. By Country - South America RNA-based Therapeutics Drug Revenue Market Share, 2018-2029
Figure 34. Brazil RNA-based Therapeutics Drug Revenue, US$, Mn, 2018-2029
Figure 35. Argentina RNA-based Therapeutics Drug Revenue, US$, Mn, 2018-2029
Figure 36. By Country - Middle East & Africa RNA-based Therapeutics Drug Revenue Market Share, 2018-2029
Figure 37. Turkey RNA-based Therapeutics Drug Revenue, US$, Mn, 2018-2029
Figure 38. Israel RNA-based Therapeutics Drug Revenue, US$, Mn, 2018-2029
Figure 39. Saudi Arabia RNA-based Therapeutics Drug Revenue, US$, Mn, 2018-2029
Figure 40. UAE RNA-based Therapeutics Drug Revenue, US$, Mn, 2018-2029
Figure 41. Sarepta Therapeutics RNA-based Therapeutics Drug Revenue Year Over Year Growth US$, Mn & 2018-2023
Figure 42. Ionis Pharmaceuticals RNA-based Therapeutics Drug Revenue Year Over Year Growth US$, Mn & 2018-2023
Figure 43. Alnylam RNA-based Therapeutics Drug Revenue Year Over Year Growth US$, Mn & 2018-2023
Figure 44. Biogen RNA-based Therapeutics Drug Revenue Year Over Year Growth US$, Mn & 2018-2023
Figure 45. Nippon Shinyaku RNA-based Therapeutics Drug Revenue Year Over Year Growth US$, Mn & 2018-2023
Figure 46. Sobi RNA-based Therapeutics Drug Revenue Year Over Year Growth US$, Mn & 2018-2023
Figure 47. Novartis RNA-based Therapeutics Drug Revenue Year Over Year Growth US$, Mn & 2018-2023
Figure 48. BioNTech RNA-based Therapeutics Drug Revenue Year Over Year Growth US$, Mn & 2018-2023
Figure 49. Pfizer RNA-based Therapeutics Drug Revenue Year Over Year Growth US$, Mn & 2018-2023
Figure 50. Moderna Therapeutics RNA-based Therapeutics Drug Revenue Year Over Year Growth US$, Mn & 2018-2023
Figure 51. Jazz Pharmaceuticals RNA-based Therapeutics Drug Revenue Year Over Year Growth US$, Mn & 2018-2023
Figure 52. CureVac RNA-based Therapeutics Drug Revenue Year Over Year Growth US$, Mn & 2018-2023
Figure 53. Regulus Therapeutics RNA-based Therapeutics Drug Revenue Year Over Year Growth US$, Mn & 2018-2023
Figure 54. ProQR RNA-based Therapeutics Drug Revenue Year Over Year Growth US$, Mn & 2018-2023
Figure 55. Secarna RNA-based Therapeutics Drug Revenue Year Over Year Growth US$, Mn & 2018-2023
Figure 56. MiNA Therapeutics RNA-based Therapeutics Drug Revenue Year Over Year Growth US$, Mn & 2018-2023
Figure 57. Sylentis RNA-based Therapeutics Drug Revenue Year Over Year Growth US$, Mn & 2018-2023
Figure 58. Arrowhead RNA-based Therapeutics Drug Revenue Year Over Year Growth US$, Mn & 2018-2023
Figure 59. Silence Therapeutics RNA-based Therapeutics Drug Revenue Year Over Year Growth US$, Mn & 2018-2023
Figure 60. Dicerna RNA-based Therapeutics Drug Revenue Year Over Year Growth US$, Mn & 2018-2023
